Inventor · disambiguated record
Jennifer Kozak
Also filed as: KOZAK JENNIFER AIDEN · Kozak Jennifer
20 granted patents·2 pending applications·90 citations·filing 2013–2023
94Inventor score
Top patents by PatentIndex Score
22 records- 0197US11420965B2Pyrimidine compound as JAK kinase inhibitorTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Granted Aug 23, 2022·3 cites·18 claims
- 0297US10774080B2Pyrimidine compound as JAK kinase inhibitorTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2020·Granted Sep 15, 2020·5 cites·22 claims
- 0397US9725470B2Substituted naphthyridines as JAK kinase inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2016·Granted Aug 8, 2017·27 cites·19 claims
- 0496US11780852B2Methods for treating Crohn's disease using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrileTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Granted Oct 10, 2023·3 cites·55 claims
- 0596US10988470B2Pyrimidine compound as JAK kinase inhibitorTHERAVANCE BIOPHARMA R & D IP LLC·Filed 2020·Granted Apr 27, 2021·3 cites·19 claims
- 0696US10562894B2Pyrimidine compound as JAK kinase inhibitorTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Feb 18, 2020·7 cites·19 claims
- 0796US10308646B2Pyrimidine compound as JAK kinase inhibitorTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Jun 4, 2019·11 cites·32 claims
- 0895US10028960B2Pyrimidine compounds as JAK kinase inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2017·Granted Jul 24, 2018·18 cites·13 claims
- 0993US11970481B1Substituted pyridine derivatives as SARM1 inhibitorsNURA BIO INC·Filed 2023·Granted Apr 30, 2024·4 cites·18 claims
- 1092US10947254B2Methods for treating ulcerative colitis using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrileTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Mar 16, 2021·3 cites·56 claims
- 1189US12358931B23-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl) propanenitrile as a JAK kinase inhibitorTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2023·Granted Jul 15, 2025·0 cites·5 claims
- 1289US11110095B2Pyrimidine compounds as JAK kinase inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Sep 7, 2021·3 cites·22 claims
- 1388US12172994B2Pyrimidine compound as JAK kinase inhibitorTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2023·Granted Dec 24, 2024·0 cites·19 claims
- 1484US11590116B2Substituted pyridines and methods of useTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2020·Granted Feb 28, 2023·1 cites·25 claims
- 1583US10952996B2ALK5 inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Mar 23, 2021·2 cites·20 claims
- 1682US11814377B2Pyrimidine compound as JAK kinase inhibitorTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2022·Granted Nov 14, 2023·0 cites·19 claims
- 1771US2023399312A1Substituted pyrimidines and methods of useTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2023·Application pending·0 cites
- 1870US2023218597A1Substituted pyridines and methods of useTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2023·Application pending·0 cites
- 1965US11673879B2Substituted pyrimidines and methods of useTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Granted Jun 13, 2023·0 cites·23 claims
- 2063US12404265B2Substituted pyridine derivatives as SARM1 inhibitorsNURA BIO INC·Filed 2021·Granted Sep 2, 2025·0 cites·16 claims
- 2162US11730720B2ALK5 inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2020·Granted Aug 22, 2023·0 cites·28 claims
- 2251US8921580B2Methods and systems for the formation of cyclic carbonatesMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Granted Dec 30, 2014·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Jennifer Kozak files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →